We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

82 hedge funds and large institutions have $270M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

470% more call options, than puts

Call options by funds: $974K | Put options by funds: $171K

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

2% less capital invested

Capital invested by funds: $275M → $270M (-$4.85M)

6% less funds holding

Funds holding: 87 → 82 (-5)

Holders
82
Holders Change
-5
Holders Change %
-5.75%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
27
Reduced
26
Closed
14
Calls
$974K
Puts
$171K
Net Calls
+$803K
Net Calls Change
+$404K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$35.7M
2
GTC
Ghost Tree Capital
New York
+$9.04M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.95M
4
Goldman Sachs
Goldman Sachs
New York
+$2.05M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.82M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$8.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.47M
3
ORI
Oak Ridge Investments
Illinois
-$2.21M
4
NSEDCP
NJ State Employees Deferred Compensation Plan
New Jersey
-$608K
5
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$1.04M -$107K -1,891 -9%
Jennison Associates
27
Jennison Associates
New York
$907K – – –
HCM
28
Highbridge Capital Management
New York
$853K +$896K +15,867 New
Millennium Management
29
Millennium Management
New York
$852K +$895K +15,844 New
VIA
30
Vident Investment Advisory
Georgia
$850K +$149K +2,634 +20%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$845K +$888K +15,720 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$791K +$4.52K +80 +0.5%
CM
33
Crestline Management
Texas
$764K +$803K +14,220 New
TA
34
Teachers Advisors
New York
$648K – – –
Citadel Advisors
35
Citadel Advisors
Florida
$633K +$666K +11,784 New
AA
36
ALPS Advisors
Colorado
$621K -$76.5K -1,354 -10%
CS
37
Candriam SCA
Luxembourg
$618K -$3.79K -67 -0.6%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$454K +$65.5K +1,160 +16%
AllianceBernstein
39
AllianceBernstein
Tennessee
$442K -$37.3K -660 -7%
ProShare Advisors
40
ProShare Advisors
Maryland
$429K -$115K -2,028 -20%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$424K +$11.9K +210 +3%
Swiss National Bank
42
Swiss National Bank
Switzerland
$414K – – –
PCM
43
Piermont Capital Management
Missouri
$386K +$406K +7,180 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$324K +$40.3K +713 +13%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$290K -$7.29K -129 -2%
VEA
46
Virtus ETF Advisers
New York
$275K +$27.7K +490 +11%
SSA
47
Schonfeld Strategic Advisors
New York
$270K +$283K +5,018 New
Wells Fargo
48
Wells Fargo
California
$259K -$452 -8 -0.2%
RJA
49
Raymond James & Associates
Florida
$252K – – –
Barclays
50
Barclays
United Kingdom
$251K +$150K +2,658 +132%
1
2
3 4

KDNY Hedge Fund Activity: Q1 2017 in Review

82 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q1 2017, worth a combined $270M — down 1.8% from $275M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KDNY positions and 14 closed out — a net gain of 1 holder — while 27 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $35.7M. The largest seller was BVF Inc, exiting entirely with an estimated $8.5M sold.

  • 82 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q1 2017, down from 87 in Q4 2016.
  • Funds reported $270M of Chinook Therapeutics, Inc. Common Stock stock for Q1 2017, down 1.8% quarter-over-quarter.
  • 15 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q1 2017 and 14 closed out, a net change of +1 holder.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $35.7M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q1 2017 was BVF Inc, an estimated $8.5M sold.

Based on aggregated 13F filings for Q1 2017.